| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d74af36268a405beca3f49a935a1ea6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a353c71cecae061fbd8b57f1b1a4f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ec5d00473c46fef1b30ca66891895c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7d8bed6276525ecd380acfe0eb6be27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8c2e3744e2b462612c07afdcac7cfa |
| publicationDate |
2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2380710-C2 |
| titleOfInvention |
Treatment, diagnostics or prevention of leishmaniasis caused by various types of parasites, except that one used to produce histones, with using all of four histones h2a, h2b, h3 and h4, recovered from leishmania infantum with using vector containing nucleotides coding specified histones |
| abstract |
FIELD: medicine. n SUBSTANCE: invention aims at treatment, diagnostics or prevention of parasitic disease. There is used combination histone proteins H2A, H2B, H3 and H4 recovered from Leishmania infantum for making a pharmaceutical composition and a diagnostic aid. It involves applying a vector containing nucleotides coding specified histones. n EFFECT: invention allows treating and preventing the parasitic disease caused by one type with using histones originated from the other type. n 13 cl, 4 dwg, 5 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2647568-C2 |
| priorityDate |
2003-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |